2nd Annual Oxford Global Formulation and Drug Delivery Congress 2016 London

  • Conference Call
  • Oxford Global Con­fer­ences are proud to announce the 2nd Annual For­mu­la­tion & Drug Deliv­ery Con­gress 2016, tak­ing place on May 1819, 2016 at the Kens­ing­ton Close Hotel in Lon­don, UK.

    Our highly antic­i­pated event pro­vides a unique oppor­tu­nity for over 150 for­mu­la­tion and drug deliv­ery lead­ers to net­work and engage in sci­en­tific dis­cus­sions about the most excit­ing areas of research that will shape the future land­scape of the indus­try. The Con­gress is co-​located with the inau­gural Inhala­tion & Res­pi­ra­tory Drug Deliv­ery Con­gress 2016 cov­er­ing the devel­op­ment and for­mu­la­tion of inhaled ther­a­pies and inhala­tion devices and analytics.

    The for­mu­la­tion and drug deliv­ery mar­ket rep­re­sents a com­plex area of the indus­try that is accel­er­at­ing at a sub­stan­tial rate. The market’s expan­sion is the con­se­quence of recent advance­ments in bio­log­ics and small mol­e­cule drugs for­mu­la­tion research, advanced solid and liq­uid for­mu­la­tions strate­gies and novel drug deliv­ery tech­nolo­gies. A recent sur­vey has also high­lighted that the global drug deliv­ery tech­nol­ogy mar­ket is expected to reach $224.2 bil­lion by 2017.

    Speakers

    • Advait Bad­kar – Bio­process R&D, Pfizer
    • Stephen Buck­ley – Novo Nordisk
    • Allen C. Tem­ple­ton – For­mu­la­tion Sci­ences, Merck & Co. (MSD)
    • Mar­t­i­nus Capelle – Janssen
    • Matthew James Clemente – Con­nected Prod­uct Sys­tems, Deliv­ery and Device Research & Devel­op­ment, Eli Lilly
    • David Elder – GlaxoSmithKline
    • Patrick Garidel – Boehringer Ingelheim
    • Mar­ian Gindy – Par­enteral Prod­ucts Devel­op­ment, Merck & Co. (MSD)
    • Rene Holm – Bio­log­ics and Phar­ma­ceu­ti­cal Sci­ence, H. Lund­beck A/​S
    • Michael Keller – Bio­log­ics Tech­ni­cal & Man­u­fac­tur­ing Devel­op­ment, Novartis
    • Robert Kel­ley – Genentech
    • Anthony Leone – Pre­for­mu­la­tion, Merck & Co. (MSD)
    • Menashe Levy – Global R&D, Teva
    • Andrew Lewis – Novel Drug Deliv­ery Tech­nolo­gies, Ipsen
    • Ling Li – Pfizer
    • Brian Lobo – MedImmune
    • Justin M. Wright – Drug Deliv­ery Inno­va­tion, DDR&D Tech­nol­ogy, Eli Lilly
    • Avinash Nan­gia – R&D, Lupin Phar­ma­ceu­ti­cals, Inc.
    • Vijay Nar­ingrekar – Phar­ma­ceu­ti­cal Devel­op­ment, Bio­log­ics, Celgene
    • David Need­ham – Uni­ver­sity of South­ern Den­mark and Duke Uni­ver­sity, USA
    • Karsten Peters­son – LEO Pharma
    • Nausheen Rah­man – Bio­process Research and Devel­op­ment, Sanofi
    • Joel Richard – Pep­tides — CMCS Dreux Site, Ipsen
    • Clare Rowlinson-​Malone – Bristol-​Myers Squibb
    • Christoph Saal – Bio­an­a­lyt­i­cal Chem­istry, Merck
    • Vijay Sethu­ra­man – Novartis
    • Ahmad Sheikh – Solid State Chem­istry, AbbVie
    • Boris Shekunov – Shire
    • Kama­lin­der Singh – Phar­ma­ceu­ti­cal Tech­nol­ogy and Drug Deliv­ery, Uni­ver­sity of Cen­tral Lancashire
    • Anand Sub­ra­mony – Drug Deliv­ery & Device Devel­op­ment, MedImmune
    • Carol Thom­son – Dose Form Qual­ity Direc­tor, GlaxoSmithKline
    • Ijeoma Uchegbu – Phar­ma­ceu­ti­cal Nanoscience, Uni­ver­sity Col­lege London
    • Her­bert Wach­tel – Boehringer Ingelheim
    • Carsten Worsøe – Novo Nordisk A.S.
    • Cédric Yer­naux – Drug Prod­uct Bel­gium, GlaxoSmithKline

    Agenda

    On day one our highly esteemed speak­ers will focus on large mol­e­cule drugs for­mu­la­tion and small mol­e­cule drug deliv­ery. Pre­sen­ta­tions will cover such key areas of research as ensur­ing the qual­ity and sta­bil­ity of bio­logic for­mu­la­tions as well as the for­mu­la­tion of highly potent mol­e­cules. Enhanc­ing nanopar­ti­cles as drug deliv­ery sys­tems and var­i­ous small mol­e­cule drug deliv­ery tech­nolo­gies will also be addressed.

    Day 1 Stream 1 – Large Mol­e­cule Drugs Formulation

    • Char­ac­ter­is­tics of pep­tide & pro­tein formulations
    • Over­com­ing pro­tein & pep­tide for­mu­la­tion challenges
    • Ensur­ing the qual­ity and sta­bil­ity of bio­logic formulation
    • For­mu­la­tion chal­lenges of highly potent molecules
    • For­mu­la­tion strate­gies in early & pre-​commercial development
    • Suit­able solu­tion con­di­tions & excipients
    • Solids, liq­uids or advanced pro­tein formulations

    Day 1 Stream 2 – Small Mol­e­cule Drug Delivery

    • Recent advance­ments in small mol­e­cule drug delivery
    • Nanopar­ti­cles as drug deliv­ery systems
    • Oral-​delivery vs lipid-​based systems
    • Enhanc­ing bioavail­abil­ity with drug deliv­ery systems
    • Ver­sa­tile tech­nol­ogy for small mol­e­cule drug delivery
      • biodegrad­able silica-​based technology
      • gel – liposome-​mediated co-​delivery

    On day two del­e­gates will have the unique oppor­tu­nity to join high-​level dis­cus­sions about small mol­e­cule drugs for­mu­la­tion and large mol­e­cule drug deliv­ery. Our highly acknowl­edged speak­ers will explore novel bio­log­ics drug deliv­ery sys­tems, viral and non-​viral gene deliv­ery sys­tems and new meth­ods to deliver bio­log­ics through the blood-​brain bar­rier. Our highly acknowl­edged speak­ers will also address novel small mol­e­cule for­mu­la­tion strate­gies, nano-​formulations and amor­phous solid dispersions.

    Day 2 Stream 1 – Small Mol­e­cule Drugs Formulation

    • Suc­cess­ful for­mu­la­tion strate­gies for small molecules
    • Nano for­mu­la­tions: pre­dict­ing phys­i­cal stability
    • Oral Sus­pen­sions: sol­u­bil­ity & stability
    • Improv­ing chem­i­cal and phys­i­cal sta­bil­ity in liq­uid formulations
    • Improv­ing the bioavail­abil­ity of compounds
    • Amor­phous solid dis­per­sions: over­com­ing poor sol­u­bil­ity and dis­so­lu­tion rate

    Day 2 Stream 2 – Large Mol­e­cule Drug Delivery

    • New bio­log­ics drug deliv­ery systems
    • Increas­ing intra­cel­lu­lar deliv­ery of biologics
    • Achiev­ing long term release of antibodies
    • Gene deliv­ery sys­tems: viral and non-​viral
    • Approaches for deliv­ery of bio­log­ics across the blood-​brain barrier
    • Chal­lenges and oppor­tu­ni­ties in pro­tein and pep­tide drug delivery

    Sub­mit a Poster

    For atten­dees inter­ested in sub­mit­ting a poster, there are oppor­tu­ni­ties now avail­able. Your poster pre­sen­ta­tion will be located in the exhi­bi­tion room for two days along­side other posters from senior sci­en­tists from the phar­ma­ceu­ti­cal indus­try and aca­d­e­mic institutions.

    How to sub­mit your abstract

    We will require:

    • Poster title, Abstract (200 words or less)
    • Prin­ci­pal author, Organisation
    • Mail­ing address, Email, Tele­phone, Fax
    • Addi­tional authors

    In order to secure your board space a fee of £250 plus VAT will be required. The poster should be pre­sented as A0 (841mm x 1189mm) por­trait size. To take advan­tage of this oppor­tu­nity you need to be reg­is­tered as a paid del­e­gate over the 2 days. We have lim­ited spaces avail­able, so please reg­is­ter soon!

    starting: ending: 19.05.2016 Location: , Category:

    Timeline

    Conference START 19.05.2016 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Wrights Lane Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.